Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Plerixafor, sold under the brand name Mozobil, is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream. The stem cells are then extracted from the blood and transplanted back to the patient. The drug was developed by AnorMED, which was subsequently bought by Genzyme.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Plerixafor. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
cells stem drug cxcr4 patients studies hematopoietic use blood cell approved found cancer zinc effects interactions hours model name mozobil
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Plerixafor | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Plerixafor | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Plerixafor | ATC code | L03AX16 (WHO) | 1.00 | infobox |
| Plerixafor | CAS Number | 110078-46-1 Y | 1.00 | infobox |
| Plerixafor | CAS Number | as salt: 155148-31-5 Y | 1.00 | infobox |
| Plerixafor | ChEBI | CHEBI:125354 | 1.00 | infobox |
| Plerixafor | ChEMBL | ChEMBL18442 Y | 1.00 | infobox |
| Plerixafor | ChemSpider | 58531 Y | 1.00 | infobox |
| Plerixafor | CompTox Dashboard (EPA) | DTXSID70869520 | 1.00 | infobox |
| Plerixafor | DrugBank | DB06809 Y | 1.00 | infobox |
| Plerixafor | Elimination half-life | 3–5 hours | 1.00 | infobox |
| Plerixafor | Excretion | Kidney | 1.00 | infobox |
| Plerixafor | Formula | C28H54N8 | 1.00 | infobox |
| Plerixafor | IUPHAR/BPS | 844 | 1.00 | infobox |
| Plerixafor | KEGG | D08971 Y | 1.00 | infobox |
| Plerixafor | Legal status | CA: ℞-only | 1.00 | infobox |
| Plerixafor | Legal status | US: ℞-only | 1.00 | infobox |
| Plerixafor | Legal status | EU: Rx-only | 1.00 | infobox |
| Plerixafor | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Plerixafor | License data | US DailyMed: Plerixafor | 1.00 | infobox |
| Plerixafor | MedlinePlus | a609018 | 1.00 | infobox |
| Plerixafor | Metabolism | None | 1.00 | infobox |
| Plerixafor | Molar mass | 502.796 g·mol−1 | 1.00 | infobox |
| Plerixafor | Other names | JM 3100, AMD3100 | 1.00 | infobox |
| Plerixafor | Pregnancy category | AU: D | 1.00 | infobox |
| Plerixafor | Protein binding | Up to 58% | 1.00 | infobox |
| Plerixafor | PubChem CID | 65015 | 1.00 | infobox |
| Plerixafor | Routes of administration | Subcutaneous | 1.00 | infobox |
| Plerixafor | Trade names | Mozobil | 1.00 | infobox |
| Plerixafor | UNII | S915P5499N | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.